G Kubac1, L Malowany. 1. Internal Medicine Department, Royal Alexandra Hospitals, Edmonton, Alberta.
Abstract
OBJECTIVE: To measure exercise duration (which frequently is diminished by atrial fibrillation) and to compare the gain in exercise duration achieved by heart rate control with the gain after cardioversion. METHODS AND RESULTS: Eighteen patients (10 with structural heart condition and eight with lone atrial fibrillation) did the treadmill exercise stress test using the Bruce protocol. Resting supine heart rate was lowered below 100 beats/min by verapamil (initial exercise stress test). An exercise stress test was then repeated as often as needed to achieve 'heart rate control' (less than 130 beats/min at the end of a 3 min walk at 10 degrees elevation and 2.74 km/h speed). This heart rate control was obtained by gradual increases in verapamil dose. Subsequently, the patients were converted to normal sinus rhythm chemically (seven patients) or electrically (11 patients) and an exercise stress test was repeated. At cardioversion, patients were on antiarrhythmic therapy and verapamil was discontinued in most. All patients had left atrial size measured by echocardiogram before and after cardioversion, and all were followed for four months. Upon achieving controlled heart rate, exercise duration increased in 16 patients (average gain was 164 s). After cardioversion to normal sinus rhythm, exercise duration further increased in 13 cases with an average additional gain of 90 s. The total increase in exercise duration after cardioversion was 254 s. Post cardioversion, all patients with lone atrial fibrillation improved. A decline in exercise performance occurred in four patients with fixed cardiac output. Average gain in exercise duration was independent of drugs used. Left atrial size remained increased post cardioversion (50.4 mm before and 52 mm after). During four months of follow-up, only eight patients could continue on the same medication given for cardioversion. Three patients did not maintain normal sinus rhythm. CONCLUSIONS: Conversion to normal sinus rhythm in patients with atrial fibrillation is associated with improved exercise tolerance except in cases with fixed cardiac output. Restoration of mechanical atrial function appears to be responsible for improved exercise performance following cardioversion.
OBJECTIVE: To measure exercise duration (which frequently is diminished by atrial fibrillation) and to compare the gain in exercise duration achieved by heart rate control with the gain after cardioversion. METHODS AND RESULTS: Eighteen patients (10 with structural heart condition and eight with lone atrial fibrillation) did the treadmill exercise stress test using the Bruce protocol. Resting supine heart rate was lowered below 100 beats/min by verapamil (initial exercise stress test). An exercise stress test was then repeated as often as needed to achieve 'heart rate control' (less than 130 beats/min at the end of a 3 min walk at 10 degrees elevation and 2.74 km/h speed). This heart rate control was obtained by gradual increases in verapamil dose. Subsequently, the patients were converted to normal sinus rhythm chemically (seven patients) or electrically (11 patients) and an exercise stress test was repeated. At cardioversion, patients were on antiarrhythmic therapy and verapamil was discontinued in most. All patients had left atrial size measured by echocardiogram before and after cardioversion, and all were followed for four months. Upon achieving controlled heart rate, exercise duration increased in 16 patients (average gain was 164 s). After cardioversion to normal sinus rhythm, exercise duration further increased in 13 cases with an average additional gain of 90 s. The total increase in exercise duration after cardioversion was 254 s. Post cardioversion, all patients with lone atrial fibrillation improved. A decline in exercise performance occurred in four patients with fixed cardiac output. Average gain in exercise duration was independent of drugs used. Left atrial size remained increased post cardioversion (50.4 mm before and 52 mm after). During four months of follow-up, only eight patients could continue on the same medication given for cardioversion. Three patients did not maintain normal sinus rhythm. CONCLUSIONS: Conversion to normal sinus rhythm in patients with atrial fibrillation is associated with improved exercise tolerance except in cases with fixed cardiac output. Restoration of mechanical atrial function appears to be responsible for improved exercise performance following cardioversion.